Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Building trust in the quality of vaccines.

Atouf, Fouad; Chakrabarti, Ranjan; Uppal, Annu.

Hum Vaccin Immunother ; 18(1): 1-3, 2022 12 31.

Artículo en Inglés | MEDLINE | ID: mdl-34197244

2.

Biopharmaceutical Industry Capability Building in India: Report from a Symposium.

Uppal, Annu; Chakrabarti, Ranjan; Chirmule, Narendra; Rathore, Anurag; Atouf, Fouad.

J Pharm Innov ; 17(4): 1555-1562, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-34849178

3.

Novel pyrazole-3-carboxamide derivatives as cannabinoid-1 (CB1) antagonists: journey from non-polar to polar amides.

Sasmal, Pradip K; Reddy, D Srinivasa; Talwar, Rashmi; Venkatesham, B; Balasubrahmanyam, D; Kannan, M; Srinivas, P; Kumar, K Shiva; Devi, B Neelima; Jadhav, Vikram P; Khan, Sanjoy K; Mohan, Priya; Chaudhury, Hira; Bhuniya, Debnath; Iqbal, Javed; Chakrabarti, Ranjan.

Bioorg Med Chem Lett ; 21(1): 562-8, 2011 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-21075633

4.

Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.

Uppal, Annu; Koduri, Chaitanya Kumar; Yadlapalli, Sireesha; Chirmule, Narendra; Chakrabarti, Ranjan; Atouf, Fouad.

J Pharm Sci ; 109(10): 2958-2961, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32710904

5.

Synthesis and evaluation of N-acetyl-L-tyrosine based compounds as PPARalpha selective activators.

Kumar, Rakesh; Ramachandran, Uma; Raichur, Suryaprakash; Chakrabarti, Ranjan; Jain, Rahul.

Eur J Med Chem ; 42(4): 503-10, 2007 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-17187904

6.

The role of AMP kinase in diabetes.

Misra, Parimal; Chakrabarti, Ranjan.

Indian J Med Res ; 125(3): 389-98, 2007 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-17496363

7.

Antiobesity therapy: emerging drugs and targets.

Das, Saibal Kumar; Chakrabarti, Ranjan.

Curr Med Chem ; 13(12): 1429-60, 2006.

Artículo en Inglés | MEDLINE | ID: mdl-16719787

8.

Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR alpha/gamma dual agonist: Ragaglitazar.

Sharma, Sudhir; Sowjanya, Angaru; Kumari, Manju; Suryaprakash, Raichur; Cynthia, Gershome; Suresh, Juluri; Chakrabarti, Ranjan.

Life Sci ; 80(3): 235-44, 2006 Dec 23.

Artículo en Inglés | MEDLINE | ID: mdl-17014868

9.

Insulin sensitizing property of Indigofera mysorensis extract.

Chakrabarti, Ranjan; Damarla, Ravi K B; Mullangi, Ramesh; Sharma, V M; Vikramadithyan, Reeba K; Rajagopalan, Ramanujam.

J Ethnopharmacol ; 105(1-2): 102-6, 2006 Apr 21.

Artículo en Inglés | MEDLINE | ID: mdl-16326056

10.

Non-insulin dependent diabetes mellitus: present therapies and new drug targets.

Das, Saibal Kumar; Chakrabarti, Ranjan.

Mini Rev Med Chem ; 5(11): 1019-34, 2005 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-16307531

11.

Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.

Chakrabarti, Ranjan; Vikramadithyan, Reeba K; Misra, Parimal; Hiriyan, Jagadheshan; Raichur, Suryaprakash; Damarla, Ravi K; Gershome, Cynthia; Suresh, Juluri; Rajagopalan, Ramanujam.

Br J Pharmacol ; 140(3): 527-37, 2003 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-12970088

12.

Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.

Chakrabarti, Ranjan; Misra, Parimal; Vikramadithyan, Reeba K; Premkumar, Mamnoor; Hiriyan, Jagadheshan; Datla, Srinivas R; Damarla, Ravi K B; Suresh, Juluri; Rajagopalan, Ramanujam.

Eur J Pharmacol ; 491(2-3): 195-206, 2004 May 03.

Artículo en Inglés | MEDLINE | ID: mdl-15140637

13.

Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents.

Vajja, Bhargavi N L; Juluri, Suresh; Kumari, Manju; Kole, Labonyamoy; Chakrabarti, Ranjan; Joshi, Vishwas D.

Int Immunopharmacol ; 4(7): 901-9, 2004 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-15182729

14.

Antidiabetic and hypolipidemic activity of Helicteres isora in animal models.

Chakrabarti, Ranjan; Vikramadithyan, Reeba K; Mullangi, Ramesh; Sharma, V M; Jagadheshan, H; Rao, Y N; Sairam, P; Rajagopalan, R.

J Ethnopharmacol ; 81(3): 343-9, 2002 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12127235

15.

Pharmacotherapy of obesity: emerging drugs and targets.

Chakrabarti, Ranjan.

Expert Opin Ther Targets ; 13(2): 195-207, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-19236237

16.

Advances in antithrombotic agents.

Chakrabarti, Ranjan; Das, Saibal Kumar.

Cardiovasc Hematol Agents Med Chem ; 5(3): 175-85, 2007 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-17630943

17.

Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.

Kumar, Rakesh; Ramachandran, Uma; Khanna, Smriti; Bharatam, Prasad V; Raichur, Suryaprakash; Chakrabarti, Ranjan.

Bioorg Med Chem ; 15(3): 1547-55, 2007 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-17166722

18.

Role of PPAR in cardiovascular diseases.

Das, Saibal Kumar; Chakrabarti, Ranjan.

Recent Pat Cardiovasc Drug Discov ; 1(2): 193-209, 2006 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18221086

19.

Antihypertensive effect of ragaglitazar: a novel PPARalpha and gamma dual activator.

Mamnoor, Prem K; Hegde, Pragathi; Datla, Srinivas R; Damarla, Ravi K B; Rajagopalan, Ramanujam; Chakrabarti, Ranjan.

Pharmacol Res ; 54(2): 129-35, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16651004

20.

Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.

Madhavan, Gurram R; Chakrabarti, Ranjan; Reddy, K Anantha; Rajesh, B M; Balraju, V; Rao, P Bheema; Rajagopalan, R; Iqbal, Javed.

Bioorg Med Chem ; 14(2): 584-91, 2006 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-16198573

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Building trust in the quality of vaccines.

Biopharmaceutical Industry Capability Building in India: Report from a Symposium.

Novel pyrazole-3-carboxamide derivatives as cannabinoid-1 (CB1) antagonists: journey from non-polar to polar amides.

Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.

Synthesis and evaluation of N-acetyl-L-tyrosine based compounds as PPARalpha selective activators.

The role of AMP kinase in diabetes.

Antiobesity therapy: emerging drugs and targets.

Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR alpha/gamma dual agonist: Ragaglitazar.

Insulin sensitizing property of Indigofera mysorensis extract.

Non-insulin dependent diabetes mellitus: present therapies and new drug targets.

Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.

Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.

Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents.

Antidiabetic and hypolipidemic activity of Helicteres isora in animal models.

Pharmacotherapy of obesity: emerging drugs and targets.

Advances in antithrombotic agents.

Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.

Role of PPAR in cardiovascular diseases.

Antihypertensive effect of ragaglitazar: a novel PPARalpha and gamma dual activator.

Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.